Lupin Limited
LUPIN
Kedudukan dalam Saham
#2104
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
Harga Saham
$21.45
Modal Pasaran
$9.81B
Perubahan (1 hari)
0.25%
Perubahan (1 tahun)
-2.78%
Negara
IN
Perdagangan Lupin Limited (LUPIN)
Kategori
Healthcare
Bilangan saham terbitan bagi Lupin Limited (LUPIN)
Bilangan saham terbitan setakat June 2026: 457.19M
Menurut laporan kewangan terkini dan harga saham Lupin Limited, bilangan saham terbitan semasa ialah 457.19M. Pada akhir March 2024, syarikat mempunyai 457.24M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Lupin Limited (LUPIN) dari 2004 hingga 2026
Saham terbitan pada akhir setiap tahun
| Tahun | Saham Terbitan | Ubah |
|---|---|---|
| 2026 (TTM) | 457.19M | -0.12% |
| 2025 | 457.75M | 0.11% |
| 2024 | 457.24M | 0.04% |
| 2023 | 457.05M | 0.66% |
| 2022 | 454.04M | -0.27% |
| 2021 | 455.29M | 0.57% |
| 2020 | 452.71M | 0.10% |
| 2019 | 452.25M | -0.29% |
| 2018 | 453.54M | 0.13% |
| 2017 | 452.97M | 0.10% |
| 2016 | 452.51M | 0.17% |
| 2015 | 451.74M | 0.00% |
| 2014 | 451.74M | 0.58% |
| 2013 | 449.13M | 0.60% |
| 2012 | 446.46M | 0.20% |
| 2011 | 445.58M | 3.52% |
| 2010 | 430.42M | 4.42% |
| 2009 | 412.21M | 0.99% |
| 2008 | 408.17M | 1.65% |
| 2007 | 401.54M | 0.03% |
| 2006 | 401.41M | 0.00% |
| 2005 | 401.41M | 0.00% |
| 2004 | 401.41M | 0.00% |
Saham terbitan bagi syarikat atau pesaing yang serupa
| Syarikat | Saham Terbitan | Perbezaan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 424.80% |
IN
|
